People who are diagnosed with T-cell lymphoma are likely to find they are asked to undergo a wide variety of testing procedures. These tests are required to help doctors confirm the condition, stage the disease and even guide appropriate treatment actions. One of the tests some researchers say should be used during the treatment process especially is a PET/CT scan.
T-cell lymphoma is known to have a rather poor treatment outcome. While chemotherapy can help in some cases, other patients are likely to see a recurrence of the disease. Recurrences can prove especially difficult to treat and may lead to mortality. With that in mind, doctors have been seeing a way to better assess tumors, gauge reaction to treatment and gain more clear insights on prognosis. The PET/CT scan offers a superior way to achieve these goals, researchers say.
A positron emission tomography-computed tomography analysis provides a more in-depth, accurate look inside the body to help doctors see how tumors respond to treatments. This test is beneficial during the actual treatment process and also offers strong prognostic insights. Studies have given rise to the recommendation that this test be performed during treatment and following a full course. The insights can help doctors adjust treatment, if necessary, and may help them make the determination to introduce other options if post-treatment scans aren’t promising.
Fighting cancer development requires the ability to stop all cancer cells in their tracks. T-cell lymphoma has proven to be a difficult form of the disease to properly gauge during treatment. Routine PET/CT scan use, however, may better guide oncologists as patients go through chemo and other treatment options. While this test is no guarantee for positive results, it can help improve outcomes by better guiding treatment actions, researchers say.
People who are diagnosed with T-cell lymphoma and other forms of cancer should discuss all diagnostic and treatment procedures with their healthcare providers. The best recommendations will be based on unique case specifics.